IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q1 2025
- Shares held
- 3.04M
- +178.4K (+6.2%) vs. Q1 2025
- Total value
- $929.4K
- +$114.5K (+14.0%) vs. Q1 2025
- New holders
- 5
- 6 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 703,798 | $215.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 703,303 | $215.2K | 0.00% | +3,289+0.5% | Added |
| Vanguard Group Inc | 645,166 | $197.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 270,966 | $82.9K | 0.00% | +176,495+186.8% | Added |
| State Street Corp | 160,207 | $49.0K | 0.00% | −5,100−3.1% | Reduced |
| Northern Trust Corp | 113,407 | $34.7K | 0.00% | 00.0% | Unchanged |
| Dearborn Partners LLC | 84,401 | $25.8K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 65,541 | $20.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 55,025 | $16.8K | 0.00% | +55,025 | New |
| Virtu Financial LLC | 46,892 | $14.0K | 0.00% | +46,892 | New |
| Truist Financial Corp | 36,667 | $11.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 36,308 | $11.1K | 0.00% | +36,307+3,630,700.0% | Added |
| Commonwealth Equity Services, LLC | 34,948 | $11.0K | 0.00% | +348+1.0% | Added |
| Morgan Stanley | 17,707 | $5.42K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,765 | $4.21K | 0.00% | −18,318−57.1% | Reduced |
| Jane Street Group, LLC | 13,316 | $4.08K | 0.00% | +13,316 | New |
| Tower Research Capital LLC (TRC) | 11,899 | $3.64K | 0.00% | −1,454−10.9% | Reduced |
| Two Sigma Securities, LLC | 11,834 | $3.62K | 0.00% | +11,834 | New |
| Group One Trading, L.P. | 7,187 | $2.20K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 3,000 | $930 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 727 | $223 | 0.00% | +123+20.4% | Added |
| CIBC Private Wealth Group, LLC | 655 | $200 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 178 | $55 | 0.00% | +178 | New |
| FMR LLC | 108 | $33 | 0.00% | +103+2,060.0% | Added |
| Hurley Capital, LLC | 100 | $31 | 0.00% | 00.0% | Unchanged |
| DHJJ Financial Advisors, Ltd. | 80 | $25 | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 30 | $10 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 612 | $0 | 0.00% | −100−14.0% | Reduced |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −140,510−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |